Search PubMed⌕ Search

Biomedical subjects

C Flamigni

Publications and source records attributed to C Flamigni.

At least 235 records · Page 13Linked to original sources
PubMedDate not supplied

Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?

One group of 21 and one group of 22 anovulatory women with polycystic ovaries (PCO) underwent induction of ovulation with human urinary follicle stimulating hormone (HU-FSH)/human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG)/HCG, respectively. No statistically significant differences in ovulation rate were found between patients treated with HU-FSH (95.2%) and those treated with HMG (100%). Eight (38.1%) and 11 (50.0%) patients conceived, six (28.5%) and eight (36.3%) delivered, and two (9.5%) and three (13.6%) aborted with HU-FSH and HMG, respectively. No multiple pregnancies occurred. Serum 17 beta-estradiol (E2) levels and the number of maturing follicles prior to HCG injection were significantly higher with HU-FSH than HMG, while there were no differences in the diameter of the dominant follicle before HCG. Ovarian hyperstimulations were discovered more frequently after HU-FSH/HCG (40%) than HMG/HCG treatments (22.2%). These data do not confirm an effective advantage in the use of HU-FSH in ovulation induction in cases of PCO.

Anovulation↗
PubMedDate not supplied

The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.

Hormone profile and ovarian morphology were studied in two groups of adolescents (group 1:19 girls with slight signs of hyperandrogenism; group 2: 14 normal adolescents) in basal conditions and during a contraceptive combination of 30 micrograms ethinyl estradiol (EE) and 150 micrograms desogestrel (D). Treatment was associated with a low incidence of side effects in both groups. In group 1, acne generally improved within 12 months while hirsutism was only reduced in some subjects (58%) after 12 months of therapy (basal hair score 8.50 +/- 1.60 vs 5.81 +/- 1.53 p less than 0.001). Significant falls in plasma levels of LH, total and free testosterone and an increase in sex-hormone-binding globulin levels were observed during treatment especially in group 1. High percentage of multifollicular ovaries (75%) characterized hyperandrogenic subjects. Ovarian volume and number of follicles, higher in group 1 than 2 in basal conditions, showed a significant reduction in both groups and normal ovarian morphology was restored in hyperandrogenic subjects. Considering the high incidence of hyperandrogenemia in adolescence and its implications, our data suggest that the EE.D combination suits adolescent biological condition and is one of the suitable contraceptive methods in adolescents which also has therapeutic effects.

Acne Vulgaris↗
PubMedDate not supplied

Danazol reverses endometrial hyperplasia to normal endometrium.

Danazol, an isoxazol derivate of ethinyltestosterone, was used in the treatment of thirtyone postmenopausal patients with endometrial hyperplasia at the dose of 400 mg/day for three months. A profound growth-inhibitory effect of danazol on human endometrium was previously suggested. The present study shows that this compound is effective to reverse the endometrial hyperplasia to normal endometrium in 97% of cases. Atrophic changes of endometrial hyperplasia to normal endometrium after danazol-treatment were observed in 68% of patients. These results strongly suggest that danazol has a significant antiproliferative effect on the endometrium.

Danazol↗
PubMedDate not supplied

A comparison of the delta copper T and the copper T 200 in Bologna, Italy.

An analysis is presented of a comparative study of the Delta T and Copper T 200 IUDs. A total of 195 postabortion insertions was performed between March 1981 and August 1982. All insertions were performed with an inserter. Primary bleeding/pain complaints after insertion were largely related to intermenstrual problems, with spotting the most frequently reported. Nine women had their devices removed for PID. One pregnancy occurred at ten months in the Delta T group. Both groups had one expulsion/displacement. Eight devices in each group were removed for bleeding/pain. Two women in the TCu group had their devices removed for personal reasons. The 6-months continuation rates for the two groups were 85.5 for the Delta T group and 82.2 for the TCu group. The 6-months follow-up rate for the Delta T group was 39.4 and 38.8 for the TCu group.

Abortion, Induced↗
PubMedDate not supplied

Uterine pathology and infertility.

The authors describe the factors influencing implantation with reference to uterine pathology; the role that it plays both in the case of failure of implantation and in the case of repeated abortions is discussed and the techniques of treatment in the presence of uterine pathology affecting fertility are listed.

Abortion, Habitual↗
PubMedDate not supplied

Changes in the uterine vasculature during the menstrual cycle.

The uterine vasculature of 15 uteri, which were hysterectomized for cervical cancer, has been studied. The removed uteri were immediately cannulated with four catheters inserted into the uterine arteries and veins and the vasculature was flushed with a saline-heparin solution. The vessels were clearly visualized by injection of radioopaque medium or of 5-10 ml prevulcanized natural latex, followed by tissue digestion. Histological studies of uterine specimens were also carried out for histomorphologic studies. The results show differences in the architecture of uterine vasculature, related to the cyclic hormonal changes. Most of the modifications occur in the radial and coiled arteries as well as in "venous lakes" of the endometrium.

Angiography↗
PubMedDate not supplied

Luteinized unruptured follicle syndrome: hormone assay on peritoneal fluid in a laparoscopic study of infertile women.

33 infertile women with normal ovulatory cycles were investigated for the presence of a Luteinized Unruptured Follicle Syndrome (L.U.F.) using steroid hormone assays in peritoneal fluid and laparoscopic visualization of ovulation stigmata. We failed to identify a stigma in 36% (12) of the patients in the early luteal phase, 1 subject had a cystic corpus luteum and in 4 cases no diagnosis was made due to the presence of adhesions. The mean hormone concentrations in PF were significantly higher when the stigma was present (17-beta-estradiol, P less than 0,05; progesterone, P less than 0,01; 17-oh-progesterone, P less than 0,05). The two groups (with and without ovulation stigmata) showed no differences in plasma levels of Estradiol (E2) and Progesterone (P). Stigmata were detected only in 17% of subjects with concomitant endometriosis. 3 patients with a luteal phase defect showed low levels of steroids in PF in spite of the presence of an ovulation stigma.

17-alpha-Hydroxyprogesterone↗
PubMedDate not supplied

Preliminary report on progesterone effect on peripheral estrone sulfate metabolism.

The effect of progesterone (P) on peripheral estrone sulfate (E1S) was investigated in postmenopausal women using E1S constant infusions. The metabolic clearance rate of E1S (MCRE1S) was significantly lowered by P administration (p less than 0.01), while no significant changes were observed for E1S----E1 conversion ratio. The present findings suggest that P can affect the E1S peripheral fate inducing deep changes in estrogen equilibrium.

Estradiol↗
PubMedDate not supplied

Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.

Ten infertile patients with polycystic ovaries, who failed to conceive with clomiphene citrate, were treated with human urinary follicle stimulating hormone. In the same group of subjects, three cycles of treatment were performed to induce ovulation and pregnancy. Ovulation occurred in sixteen cycles out of eighteen. Eight pregnancies were obtained; three ended in abortions, one was an extra-uterine pregnancy and four resulted in normal deliveries. No cases of real hyperstimulation were observed.

Adult↗
PubMedDate not supplied

Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) expression in different endometrial cancers.

The role of epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) in endometrial cancer is still controversial. In this study the immunostaining of EGF-R and TGFA, investigated in 44 cases, proved to be related to endometrial cancer histotype regardless of the tumor grade or the extent of myometrial invasion. In fact, EGF-R expression was observed in 12.5% (1/8) of cases with classical endometrioid adenocarcinoma, in 91% (10/11) with endometrial adenocarcinoma and benign squamous metaplasia, and in 35% (6/17) with adenosquamous carcinoma. TGFA expression was concomitant with EGF-R in the first two histotypes, and was present in about 50% (9/17) of the latter. Conversely, in mucinous and serous papillary adenocarcinoma, EGF-R and TGFA immunostaining was not observed. In conclusion, EGF-R positivity was observed in endometrial cancer with squamous differentiation, especially in those cases with benign squamous metaplasia. EGF-R and TGFA coexpression appeared as a constant feature of benign squamous metaplasia.

Endometrial Neoplasms↗
PubMedDate not supplied

[The ovary at puberty].

Our investigation includes two groups of subjects in which the relationships between ovarian growth, steroidogenesis and gonadotropin secretion were studied. The first group consists of premenarchal girls studied in a cross-sectional program; the second group includes girls after menarche with irregular cycles who were investigated with a long term follow up. In the first group an increase in ovarian volume and in the number of developing follicles were seen with increasing chronological age and pubertal stages. With advancing pubertal development, a progressive increase of LH pulse frequency and amplitude can be observed. These variables appear strongly linked to the ovarian morphological and functional development as the significant correlation between LH mean levels and pulsatile characteristics on the one hand, and ovarian volume and steroid production on the other hand demonstrate. In the maturational stage just before menarche, the ovaries may show increased volume and a very dishomogeneous structure; ovarian steroidogenesis may be often mainly directed towards the androgen synthesis. After menarche ovarian volume and structure continue to change and normal or enlarged ovaries, with homogeneous, multifollicular or polycystic structure can be frequently observed. However normal and homogeneous ovaries prevail in adolescents with regular and ovulatory cycles, while enlarged and dishomogeneous ovaries prevail in irregular anovulatory cycles. A trend towards normal adult ovarian morphology and structure is present in ovulatory subjects with normal gonadotropin pulsatile release and steroid synthesis. On the other hand, deranged gonadotropin profiles imply irregular cycles anovolation, hyperandrogenemia and enlarged polycystic ovaries during adolescence.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗